(Q52091938)

22 April 2018

title

Disturbance of recent memory function in parkinsonian patients on anticholinergic therapy. (English)

1 reference

22 April 2018

1 reference

W C Koller

1

1 reference

22 April 2018

publication date

1 June 1984

1 reference

22 April 2018

published in

Cortex

1 reference

22 April 2018

volume

20

1 reference

22 April 2018

issue

2

1 reference

22 April 2018

page(s)

307-311

1 reference

22 April 2018

Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0010-9452%2884%2980051-9

Neurotransmitter-related enzymes in senile dementia of the alzheimer type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-9452%2884%2980051-9

Confusion, dementia and anticholinergics in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-9452%2884%2980051-9

Memory and the hippocampal complex. II. Is memory a multiple process?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-9452%2884%2980051-9

Memory decline in the aged: treatment with lecithin and physostigmine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-9452%2884%2980051-9

Human memory and the cholinergic system. A relationship to aging?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-9452%2884%2980051-9

Considerations in the management of parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-9452%2884%2980051-9

Parkinsonism: onset, progression, and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-9452%2884%2980051-9

Behavioral alterations and the therapy of parkinsonism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-9452%2884%2980051-9

Effects of physostigmine and lecithin on memory in Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-9452%2884%2980051-9

The prevalence, natural history and dementia of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-9452%2884%2980051-9

Pre- and postsynaptic neurochemical alterations in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-9452%2884%2980051-9

Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-9452%2884%2980051-9

Effects of anticholinergic drugs on memory in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-9452%2884%2980051-9

Human Serial Learning: Enhancement with Arecholine and Choline Impairment with Scopolamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-9452%2884%2980051-9

Psychotoxic Effects of Benzhexol Hydrochloride (Artane)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-9452%2884%2980051-9

Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-9452%2884%2980051-9

A Standardized Memory Scale for Clinical Use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-9452%2884%2980051-9

Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-9452%2884%2980051-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-9452%2884%2980051-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0010-9452(84)80051-9

1 reference

22 April 2018

PubMed ID

6744901

1 reference

22 April 2018